Odyssey Therapeutics, Inc.
ODTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001882782
No open-market purchases or sales by Odyssey Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $652.9M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Odyssey Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- +59 vs. Q1 2026
- Shares held
- 34.9M
- +34.9M vs. Q1 2026
- Total value
- $652.9M
- +$652.9M vs. Q1 2026
- New holders
- 59
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ODTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $652.9M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Odyssey Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 5,179,262 | $96.9M | 0.00% | +5,179,262 | New |
| Sr One Capital Management, LP | 3,794,883 | $71.0M | 6.83% | +3,794,883 | New |
| TPG GP A, LLC | 3,690,146 | $69.0M | 1.38% | +3,690,146 | New |
| Lightspeed Management Company, L.L.C. | 3,608,443 | $67.5M | 2.81% | +3,608,443 | New |
| OrbiMed Advisors LLC | 3,001,198 | $56.2M | 1.06% | +3,001,198 | New |
| Sanofi | 1,991,918 | $37.3M | 6.98% | +1,991,918 | New |
| Deerfield Management Company, L.P. (Series C) | 1,046,139 | $19.6M | 0.20% | +1,046,139 | New |
| Sands Capital Ventures, LLC | 875,000 | $16.4M | 2.67% | +875,000 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 831,656 | $15.6M | 1.87% | +831,656 | New |
| General Catalyst Group Management, LLC | 810,272 | $15.2M | 8.04% | +810,272 | New |
| Affinity Asset Advisors, LLC | 766,346 | $14.3M | 0.70% | +766,346 | New |
| Adage Capital Partners GP, L.L.C. | 725,000 | $13.6M | 0.02% | +725,000 | New |
| Vanguard Capital Management LLC | 720,440 | $13.5M | 0.00% | +720,440 | New |
| Foresite Capital Management V, LLC | 713,105 | $13.3M | 3.68% | +713,105 | New |
| Vivo Capital, LLC | 575,000 | $10.8M | 0.98% | +575,000 | New |
| EcoR1 Capital, LLC | 555,555 | $10.4M | 0.52% | +555,555 | New |
| Logos Global Management LP | 521,736 | $9.76M | 0.42% | +521,736 | New |
| Marshall Wace, LLP | 492,697 | $9.22M | 0.01% | +492,697 | New |
| Price T Rowe Associates Inc | 471,987 | $8.83M | 0.00% | +471,987 | New |
| Catalio Capital Management, LP | 457,839 | $8.57M | 1.61% | +457,839 | New |
| Redmile Group, LLC | 425,000 | $7.95M | 0.53% | +425,000 | New |
| Balyasny Asset Management LLC | 393,862 | $7.37M | 0.01% | +393,862 | New |
| Woodline Partners LP | 345,746 | $6.47M | 0.02% | +345,746 | New |
| Franklin Resources Inc | 275,022 | $5.15M | 0.00% | +275,022 | New |
| Boxer Capital Management, LLC | 275,000 | $5.15M | 0.39% | +275,000 | New |
| BlackRock, Inc. | 240,679 | $4.50M | 0.00% | +240,679 | New |
| Citadel Advisors LLC | 222,450 | $4.16M | 0.00% | +222,450 | New |
| Siren, L.L.C. | 200,000 | $3.74M | 0.08% | +200,000 | New |
| Geode Capital Management, LLC | 189,488 | $3.55M | 0.00% | +189,488 | New |
| Cormorant Asset Management, LP | 175,000 | $3.27M | 0.17% | +175,000 | New |
| Standard Life Aberdeen plc | 165,000 | $3.09M | 0.00% | +165,000 | New |
| Two Sigma Investments, LP | 156,602 | $2.93M | 0.00% | +156,602 | New |
| Goldman Sachs Group Inc | 132,801 | $2.48M | 0.00% | +132,801 | New |
| Charles Schwab Investment Management Inc | 101,531 | $1.90M | 0.00% | +101,531 | New |
| Vanguard Fiduciary Trust Co | 100,905 | $1.89M | 0.00% | +100,905 | New |
| State Street Corp | 78,950 | $1.48M | 0.00% | +78,950 | New |
| Hudson Bay Capital Management LP | 72,918 | $1.36M | 0.01% | +72,918 | New |
| UBS Group AG | 68,758 | $1.29M | 0.00% | +68,758 | New |
| Ensign Peak Advisors, Inc | 64,621 | $1.21M | 0.00% | +64,621 | New |
| Seven Grand Managers, LLC | 50,000 | $935.5K | 0.04% | +50,000 | New |
| Eversept Partners, LP | 49,658 | $929.1K | 0.05% | +49,658 | New |
| Tudor Investment Corp Et Al | 44,171 | $826.4K | 0.00% | +44,171 | New |
| Northern Trust Corp | 34,588 | $647.1K | 0.00% | +34,588 | New |
| Manufacturers Life Insurance Company, The | 32,125 | $601.1K | 0.00% | +32,125 | New |
| TD Asset Management Inc | 29,134 | $545.1K | 0.00% | +29,134 | New |
| JPMorgan Chase & Co | 27,787 | $524.9K | 0.00% | +27,787 | New |
| Ghisallo Capital Management LLC | 25,000 | $467.8K | 0.01% | +25,000 | New |
| Burkehill Global Management, LP | 20,000 | $374.2K | 0.01% | +20,000 | New |
| D. E. Shaw & Co., Inc. | 19,848 | $371.4K | 0.00% | +19,848 | New |
| XTX Topco Ltd | 16,552 | $309.7K | 0.00% | +16,552 | New |
| Vanguard Portfolio Management LLC | 13,685 | $256.0K | 0.00% | +13,685 | New |
| Vanguard Global Advisers, LLC | 7,948 | $148.7K | 0.00% | +7,948 | New |
| Omega Fund Management, LLC | 2,893 | $54.1K | 0.03% | +2,893 | New |
| Legal & General Group Plc | 2,000 | $37.3K | 0.00% | +2,000 | New |
| Wells Fargo & Company | 1,795 | $33.6K | 0.00% | +1,795 | New |
| Morgan Stanley | 1,772 | $33.2K | 0.00% | +1,772 | New |
| Barclays PLC | 1,459 | $27.3K | 0.00% | +1,459 | New |
| Citigroup Inc | 511 | $9.56K | 0.00% | +511 | New |
| Tower Research Capital LLC (TRC) | 193 | $3.61K | 0.00% | +193 | New |